Merus
Why Robinhood?
You can watch Merus and buy or sell other stocks, ETFs, and their options commission-free!About MRUS
Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors.
MRUS Key Statistics
Stock Snapshot
With a market cap of 6.83B, Merus(MRUS) trades at $90.00. The stock has a price-to-earnings ratio of -16.87.
On 2026-07-06, Merus(MRUS) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Merus(MRUS) stock has reached 0, versus its average volume of 343.5K.
The stock's 52-week range extends from a low of $33.19 to a high of $97.14.
The stock's 52-week range extends from a low of $33.19 to a high of $97.14.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.